Note: This website was automatically translated, so some terms or nuances may not be completely accurate.
Dentsu Inc. Launches Cross-Functional Organization "Smartcell & Design" to Apply Genome Technology to Business
The text of the Dentsu Inc. news release distributed on September 12 is as follows.
September 12, 2017
Dentsu Inc. Launches Cross-Functional Organization "Smartcell & Design" to Apply Genome Technology to Business
Dentsu Inc. (Headquarters: Minato-ku, Tokyo; President: Toshihiro Yamamoto) today launched "Smartcell & Design" (*1) (URL: www.smartcell.design ), a cross-organizational unit gathering domestic and international expertise on genome technology for business application.
In the biofield, recent technological innovations in genome analysis and editing have enabled significant cost reductions and accelerated processes. While the medical field is entering the era of personal genomes (*2), projections (*4) also indicate that by 2030, the industrial sector (smart cell industry) will account for approximately 40% of the bioindustry. This is driven by the spread of smart cells (*3) beyond medicine into fields such as food, clothing, energy, and chemical raw materials.
Focusing on business design utilizing smart cells, our company has been involved in diverse initiatives, such as the "Smartcell & Design Kids Event" (*5), through networking with global authorities and research institutions in genome editing and synthetic biology.
Looking ahead, we aim to become an organization that proactively anticipates and flexibly responds to customer needs, preparing for a society where the Smart Cell Industry—highly compatible with other advanced technologies like AI (Artificial Intelligence) and IoT (Internet of Things)—fully takes root.
Our services extend beyond the communication domain to encompass diverse areas such as business development ideas and solutions.
Therefore, our team consists not only of leading experts in the genome and smart cell fields but also of a hybrid team of specialists and non-specialists capable of connecting and maximizing the value of technology across diverse industries. We will continue to strengthen our structure with an open innovation stance, anticipating broad future expansion.
In genome-related fields such as industry, agriculture, materials science, healthcare, and energy, we will provide services and solutions that benefit daily life with ideas and implementation methods that overturn existing assumptions, contributing to the realization of a prosperous society.
■"Smartcell & Design" Logo Mark

※1 Smartcell & Design is a trademark applied for by Dentsu Inc.
※2 Personalized Genomic Medicine: The practice of individuals undergoing genetic analysis to receive personalized gene therapy and preventive medicine.
※3 Smart Cell: A biological cell whose functions are highly designed and whose expression is controlled using technologies such as genome editing.
※4 From "The Bioeconomy to 2030: designing a policy agenda," OECD, 2009, and the Interim Report "New Trends Created by Biotechnology [The Dawn of the Smart Cell Industry Era]," Ministry of Economy, Trade and Industry.
※5 Smartcell & Design Kids Event: An event designed to introduce elementary and junior high school students—who will support future society—to the concepts of genomes and smart cells at an early stage, encouraging them to consider potential applications for society.
www.smartcell.design/projects/kids/genomekids_170820/
Was this article helpful?